ClinicalTrials.Veeva

Menu

Autonomic Dysfunction in Patients Following Bariatric Surgery: The ADiPOSE Study

Kansas City Heart Rhythm Research Foundation logo

Kansas City Heart Rhythm Research Foundation

Status

Enrolling

Conditions

Orthostatic Intolerance
Autonomic Dysfunction

Treatments

Other: Development of AD/OI after BS

Study type

Observational

Funder types

Other

Identifiers

NCT06289413
KCHRRF_ADiPOSE_0027

Details and patient eligibility

About

Observational two phase, retrospective and prospective registry study to assess the prevalence of and characterize outcomes of autonomic dysfunction (AD) in patients who undergo bariatric surgery (BS) and to better define the underlying pathophysiology of AD following BS.

Full description

Previous studies have investigated the incidence of OI (orthostatic intolerance) with BS. One recent meta-analysis only found a 5-year cumulative incidence of 4.2%, challenging reports of increased incidence. However, this same study recognized the limited and low-quality evidence investigating this phenomenon. Other meta-analyses found only four studies each that matched their search criteria, highlighting the lack of evidence. Thus, this study is designed to investigate the prevalence and better understand AD/OI after BS.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Between the age of 18 - 85 years
  • Can provide consent
  • Negative urine B-hCG
  • Continued follow-up with the bariatric surgery team.
  • BS includes one of the following: gastric bypass, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch.
  • Phase I: Underwent BS within the last 3 years
  • Phase II: Will undergo BS within the next 3 months or underwent BS in the last 30 days

Exclusion criteria

  • Unable to provide consent
  • Pregnant or breastfeeding
  • BMI < 35
  • Revision surgery of one of the following BS from above
  • Prior history of autonomic dysfunction prior to BS
  • Developed AD 72 months post-procedure
  • No evidence of AD/OI

Trial design

400 participants in 1 patient group

Development of AD/OI after BS.
Treatment:
Other: Development of AD/OI after BS

Trial contacts and locations

8

Loading...

Central trial contact

Donita Atkins

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems